RNA Shielding of P65 Is Required to Potentiate Oncogenic Inflammation in TET2 Mutated Clonal Hematopoiesis

Scientists performed scRNA and scATAC-seq in COVID-19 patients with and without TET2-mutated clonal hematopoiesis reasoning that the inflammation from COVID-19 may highlight critical downstream transcriptional targets of TET2 mutations.